Grant

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

CountryUnited States
Deadline2029-11-16 (1090 days left)
Published2026-11-03
SectorsHealth & life sciences
SourceGrants.gov (US)

Summary

Funding opportunity PAR-28-042. CFDA: 93.CA1

The buyer, the value, the full description and the link to the official notice are available with a free account.